Comparison of the effect of Venlafaxine and Oxybutynin in the Treatment of Hot Flashes
Phase 2
- Conditions
- Breast Cancer.Malignant neoplasm of breast
- Registration Number
- IRCT20210822052256N1
- Lead Sponsor
- Esfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Female
- Target Recruitment
- 64
Inclusion Criteria
18 years or older
Pre-menopause
At least 6 months have passed since the last Menstrual Period.
Hot Flashes attacks
Willingness to participate in the study
Exclusion Criteria
Uncontrolled Hypertension
Chronic Heart Failure
Chronic Kidney Disease
Chronic Lung Failure
Chronic Liver Failure
Pregnancy
Breast feeding
Taking Anti Depressant Drugs
Taking other Medications to control Hot Flashes over the past Two weeks
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Severity of Hot Flashes. Timepoint: At the beginning of the study and 8 weeks after taking Venlafaxine or Oxybutynin. Method of measurement: Check List.
- Secondary Outcome Measures
Name Time Method